Clinical Trial Update: Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update on efficacy and safety of Tenofovir Disoproxil Fumarate in Chinese patients with chronic hepatitis B and advanced fibrosis or compensated c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2022-02-14